Pharma: Page
-
Letter from the Editor
Storied Careers This is my favorite issue of the year — nothing against the other great issues we put out every month. But there is something particularly special about showcasing 100 men and women who have dedicated their lives to the life-sciences industry. They could be using their talents in ...
By Taren Grom • Aug. 1, 2017 -
Who's On The List by Section
This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured. Change Agents Danielle Bedard inVentiv Health Kathy Biberstein Alkermes Kim Carpenter HCB Health Dr. Ryan Cohlhepp Takeda Oncology Su...
By PharmaVoice Team • Aug. 1, 2017 -
Explore the Trendline➔
Getty Images
TrendlineTech for Clinical Trials
Companies that utilize these emerging technologies wisely are likely to find an edge in the increasingly competitive drug development arena.
By PharmaVoice staff -
The Collaborators
Jesse Johanson Voicing Collaborative Ideas Title: Executive VP, Director of Strategic Planning Company: McCann Echo Education: BS, Animal Science, MS, Nutritional Science, University of Wisconsin – Madison Family: Wife, Amy; children, Madeline and Michael, who have always been hugely supportive o...
By PharmaVoice Team • Aug. 1, 2017 -
Giving Back
The PharmaVOICE 100 honorees share a sincere desire to pay it forward. Philanthropy is a big part of what makes our inspired leaders tick. They generously give of their time and resources. Download PDF
By PharmaVoice Team • Aug. 1, 2017 -
Alternative Jobs
What other job would you like to attempt? They may be industry stars today, but many of our PharmaVOICE 100 discuss what they would have liked to pursue. Download PDF
By PharmaVoice Team • Aug. 1, 2017 -
Letter from the Editor
Trial transformation IBM Watson, Microsoft, Oracle, GE are among the dozens, if not hundreds, of companies that are developing and deploying game-changing technologies, tools, services, and processes focused on transforming how clinical trials are conducted. The goals are lofty, and the stakes ar...
By Taren Grom • June 1, 2017 -
Upfront
Allergan Encourages Those with Migraine to Share Experiences Through Art Allergan has unveiled Frames of Mind, an interactive campaign to promote awareness of the impact that migraine can have on patients’ everyday lives. People living with migraine are encouraged to create art submissions that v...
By PharmaVoice Team • June 1, 2017 -
Last Word
A Code of Ethics Mike Rea, CEO of IDEA Pharma, talks about the need for a unifying code of ethics for the pharmaceutical industry. PV: Why do you believe a “Code of Ethics" is necessary for the pharmaceutical industry? Rea: I think the first reason is that there isn’t one. That, for me, creates a...
By Mike Rea • Feb. 1, 2017 -
Letter from the Editor
On Tap for 2017 As this issue was going to press, the next president of the United States was still being hotly contested. But no matter if the blue states or red states prevail, the state of the pharmaceutical industry will be impacted. According to a Smith Hanley Associates report, polls found ...
By Taren Grom • Nov. 21, 2016 -
The Calendar
Coming Attractions The Connected Health Conference, Dec. 11-14, at the Gaylord National in Washington, D.C., is the largest and most diverse gathering of public sector and health and technology industry leaders working at the intersection of innovative product and service development, research, b...
By PharmaVoice Team • Nov. 21, 2016 -
Talent Pool
Pharma pool Dr. Marielle Cohard-Radice Daiichi Sankyo Announces Global Head of Development Daiichi Sankyo has appointed Marielle Cohard-Radice, M.D. as executive VP, global head of development. In this new role, Dr. Cohard-Radice reports to Glenn Gormley, M.D., Ph.D., senior executive officer and...
By PharmaVoice Team • Nov. 21, 2016 -
Letter from the Editor
Inspiration and Innovation Inspired leadership and innovative thinking are just two of the ways in which this year’s PharmaVOICE 100 can be described. Over the past dozen years we have showcased some of the most well-known names in the industry as well as the unsung heroes, each of whom are commi...
By Taren Grom • Aug. 1, 2016 -
Pharma Trax
Biopharma Sponsors Sell or Plan to Sell Biosimilar Products Trending now: Industry experts project there will be a biosimilar boom. The majority of companies with a large molecule offering plan to enter or are already involved in the biosimilar market, including companies with no internal manufa...
By PharmaVoice Team • Aug. 1, 2016 -
Who's On The List by Section
This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured. Commanders & Chiefs Julie Adrian Chandler Chicco Agency, inVentiv Health Mary Anderson Ogilvy CommonHealth Medical Educatio...
By PharmaVoice Team • Aug. 1, 2016 -
Born Leaders A Global Perspective
This year, the homelands of the PharmaVOICE 100 account for almost 20 different countries or territories — from Russia to the West Indies, from Scotland to New Zealand, and from the United States to Australia and various points in between. Six of our honorees — Ken Keller, Stu Libby, Jennifer Mat...
By PharmaVoice Team • Aug. 1, 2016 -
Bucket List
The PharmaVOICE 100 honorees have a wide range of interests. They are interested in travel, adventure, and giving back. Download PDF
By PharmaVoice Team • Aug. 1, 2016 -
The Challenges Facing Pharmaceutical Leaders
The pharmaceutical industry is at an unprecedented time in its evolution. Our PharmaVOICE 100 say the shifting influences of the patient, the payer, and technology are changing how medicines are developed and how care is delivered. The convergence of mobile technologies, diagnostics, and personal...
By PharmaVoice Team • Aug. 1, 2016 -
The Innovation Spark Catches Fire
Medical innovation can help patients live longer, healthier, and more productive lives. Innovative medicines developed by America’s biopharmaceutical research companies have helped increase childhood cancer survival rates from 58% in 1970 to 83% today and have contributed to declining death rates...
By PharmaVoice Team • Aug. 1, 2016 -
Reading List
What are they reading? The PharmaVOICE 100 are continually curious and are always eager to expand their knowledge base. This is a sample of both their professional and personal reading pursuits. Download PDF
By PharmaVoice Team • Aug. 1, 2016 -
From Product to Patient: Shifting the focus of support programs in oncology.
From Product to Patient: Shifting the focus of support programs in oncology. Empowered by the ease with which they can access information, today’s cancer patients seek a deeper understanding about their diagnoses, underlying diseases or health conditions and potential treatment options, as well a...
By Amy Grogg • Aug. 1, 2016 -
Pharma Trax
Surge in Biosimilars to Drive Significant Change in Health System Costs Trending now: Sustainable competitive markets and support for innovation, clinical education, and incentives are needed to deliver full value. Greater acceptance of biosimilar medicines in a growing number of therapy areas a...
By PharmaVoice Team • June 1, 2016 -
What's New
SBP and GSK Create Center for Translational Neuroscience Trending now: Academic-industry alliance seeks to find and validate new targets for drug development. Sanford Burnham Prebys Medical Discovery Institute (SBP), a fundamental and translational research institute, and GlaxoSmithKline (GSK), ...
By PharmaVoice Team • June 1, 2016 -
Tools of the Trade
Ogilvy CommonHealth Worldwide Launches the Ogilvy CommonHealth Marketing Cloud Trending Now: New service redefines data-driven marketing services for the life-sciences industry. Ogilvy CommonHealth Worldwide, the health behavior change specialists of Ogilvy & Mather, and a WPP company, has l...
By PharmaVoice Team • June 1, 2016 -
The Calendar
Coming Attractions The inaugural Rational Combinations 360° — June 23 – 24, 2016 Park Lane Hotel, New York, NY — is the only event addressing business aspects, novel clinical trial designs, and scientific developments for combination immunotherapies. With promising cancer immunotherapies in the c...
By PharmaVoice Team • June 1, 2016 -
HBA Rising Stars: Healthcare Vision 2020
PharmaVOICE has exclusive access to nearly 100 women leaders, who are providing their take on the trends that are expected to shape the healthcare industry in the next four years. Identified by their companies as HBA Rising Stars and Luminaries, these industry executives talk about everything fro...
By PharmaVoice Team • May 1, 2016